Sycai Medical
About Sycai Medical
Sycai Medical is a Barcelona-based medtech company founded in 2020, specializing in AI and big data solutions for early cancer detection in abdominal imaging. Their core mission is to empower radiologists and transform cancer care by enhancing diagnostic accuracy, efficiency, and early detection, ultimately improving patient outcomes and quality of life.
The company develops AI-powered medical device software that assists radiologists in automatically detecting, characterizing, and monitoring lesions in the upper abdomen from routine CT scans. Their solutions, such as PANCRA™ for pancreatic cancer and LIRVEA™ for liver cancer, analyze medical imaging tests even when cancer is not the primary reason for the scan, acting as a “digital second opinion” to identify lesions that might otherwise go unnoticed. This technology is designed to integrate seamlessly into hospital PACS (Picture Archiving and Communication System) and RIS workflows, providing a “zero-clicks assistant” that retrieves and compares previous scans, offers predictive modeling for lesion progression, and generates draft reports.
Sycai Medical’s technology aims to address the challenges of late cancer diagnosis, particularly for aggressive cancers like pancreatic, liver, and kidney cancers, which are often detected at advanced stages. By identifying pre-malignant lesions and early-stage tumors, the platform helps radiologists prioritize risky cases, fast-track interventions, and monitor lesion evolution over time. The company has obtained CE mark certification under the new EU MDR for its pancreatic cancer detection application and is actively pursuing FDA approval for the US market.
Focus Areas
Business Intelligence
| Key Investors | LUMO Labs, Ship2B Ventures, Athos Capital, Namarel Ventures, BStartup, Zubi Capital |
| Partnerships | Hospital de la Santa Creu i Sant Pau (Barcelona), Hospital de Mataró, Uniklinikum Erlangen (Germany), EUCAIM project |
| Acquisitions | unknown |
| Technology | AI-driven digital medical device, deep learning, big data, cloud-native, integrates with hospital PACS and RIS, DICOM compliant, zero-clicks assistant, Intel distribution of OpenVINO |
| FDA Clearances | 0 (in process of validation for FDA approval) cleared products (estimated) |
What Physicians Need to Know
Sycai Medical's AI solution acts as a 'zero-clicks assistant' that seamlessly integrates into existing radiology workflows, automatically analyzing every abdominal scan and providing a draft report. This helps radiologists by flagging abnormalities they might not be actively searching for, improving diagnostic accuracy and efficiency, and supporting earlier detection of critical cancers like pancreatic, liver, and kidney cancer. The system's ability to track lesion evolution and provide predictive modeling can aid in prioritizing patient monitoring and optimizing treatment responses.
Sycai Medical's system is designed for full integration with hospital PACS (Picture Archiving and Communication System) and RIS (Radiology Information System). It is fully DICOM compliant, allowing for automatic fetching of images and seamless workflow integration.
What the Web Says
Sycai Medical is a Barcelona-based startup founded in 2020 that specializes in AI-driven digital medical devices for the early diagnosis of abdominal cancers, including pancreatic, liver, and kidney cancers. Their technology aims to detect pre-malignant lesions from routine medical imaging, even when cancer isn't the primary focus of the scan, and automates patient monitoring. The company has received CE certification for its device and is being deployed in clinical settings in Spain and Italy, with plans for FDA approval in the United States. While there is information available about the company's mission and product, specific user reviews from platforms like G2, Glassdoor, Capterra, or Reddit for Sycai Medical are not readily available in the search results.
Overall: MixedStrengths
- AI-driven early detection of abdominal cancers (pancreatic, liver, kidney).
- Detects pre-malignant lesions from routine medical imaging.
- Automates patient monitoring.
- Aims to improve five-year survival rates for cancers like pancreatic cancer by enabling earlier detection.
- CE-certified device and deployed in clinical settings in Spain and Italy.
- Founded by experienced individuals with backgrounds in software development and AI in the medical sector.
Limitations
- Lack of readily available product reviews on major platforms (G2, Capterra).
- No specific employer reviews found on Glassdoor or Indeed.
- Limited public discussion or reviews on Reddit.
- Newer company (founded 2020), so long-term impact and widespread user feedback may still be developing.
Based on reviews from: Cancer Image Europe, How Barcelona's Sycai Medical is using AI to give cancer patients a fighting chance
Last updated: 2026-08-24
Videos
News, demos, and interviews about Sycai Medical.
Videos load interactively. If none appear, search YouTube for Sycai Medical →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Sycai Medical.
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]